Status:
COMPLETED
A Retrospective Study of Treatment Patterns and Clinical Outcomes in Patients With Central Nervous System Tuberculosis
Lead Sponsor:
Tongji Hospital
Conditions:
Central Nervous System Tuberculosis
Eligibility:
All Genders
Brief Summary
This is a retrospective clinical study to analyze the clinical characteristics, complications, and effects of different treatment options on long-term prognosis in patients with central nervous system...
Eligibility Criteria
Inclusion
- The patient meets the following criteria 1) or 2) or 3):
- The discharge diagnosis is central nervous system tuberculosis, refer to the ICD-10 code related to central nervous system tuberculosis.
- The discharge diagnosis was tuberculous meningitis (ICD-10: A17.000), or tuberculous cerebrospinal meningitis (ICD-10: A17.001), or tuberculous meningoencephalitis (ICD-10: A17.803 ), or tuberculous encephalitis (ICD-10: A17.804), or tuberculous brain abscess (ICD-10: A17.805), or spinal tuberculosis (ICD-10: A17.806), or tuberculous encephalitis Water (ICD-10: A17.807).
- Tuberculous meningitis diagnosed according to the "Guidelines for Diagnosis and Treatment of Central Nervous System Tuberculosis in China (2019 Edition)"
- Age and gender are not limited.
Exclusion
- Patients with no clear diagnosis at discharge.
- Patients judged by the investigator to be unsuitable for inclusion in this protocol.
Key Trial Info
Start Date :
August 22 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 26 2023
Estimated Enrollment :
638 Patients enrolled
Trial Details
Trial ID
NCT06011915
Start Date
August 22 2017
End Date
July 26 2023
Last Update
August 28 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
2
Wuhan Pulmonary Hospital(Wuhan Institute for Tuberculosis Control)
Hubei, Wuhan, China, 430030